Knowledge Center
Article / Jun 08, 2009
ËÄÉ«AV Shapes China Manufacturing Site
Source:
C&EN, 8 June, 2009
ËÄÉ«AV may have made itself a name as a first-class manufacturer of regulated active pharmaceutical ingredients (APIs), but it still needs to compete on price for some of its business. As in many industries, one of the best ways to lower cost is to have a manufacturing base in China. That is what ËÄÉ«AV did in March 2008 when it acquired a 75% stake in Hisyn Pharmaceutical, an API manufacturer in Taizhou, Zhejiang province. The site is a four-hour drive from Shanghai.
Related links
Also in the Knowledge Center
/ Mar 10, 2021
Webinar - Development Strategies for Expediting Time-to-Market of Spray Dried Amorphous Solid Dispersions
Read more
Scientific Article
/ Feb 24, 2021
Webinar - Computational Methods and High Throughput Screening in the Formulation of ASDs
Read more
Scientific Article
/ Feb 12, 2021
Webinar - From Lab to Commercial: Fully Integrated Solutions for Dry Powder Inhalation
Read more
Scientific Article